Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Surveillance of Rifampicin Resistance With GeneXpert MTB/RIF in the National Reference Laboratory for Tuberculosis at the Institut Pasteur in Bangui, 2015-2017.

Autor: Farra A; National Reference Laboratory for Tuberculosis, Institut Pasteur of Bangui, Bangui, Central African Republic., Manirakiza A; Epidemiology Unit, Institut Pasteur of Bangui, Bangui, Central African Republic., Yambiyo BM; Epidemiology Unit, Institut Pasteur of Bangui, Bangui, Central African Republic., Zandanga G; National Reference Laboratory for Tuberculosis, Institut Pasteur of Bangui, Bangui, Central African Republic., Lokoti B; National Reference Laboratory for Tuberculosis, Institut Pasteur of Bangui, Bangui, Central African Republic., Berlioz-Arthaud A; Medical Analysis Laboratory, Institut Pasteur of Bangui, Bangui, Central African Republic., Ngaya G; Medical Analysis Laboratory, Institut Pasteur of Bangui, Bangui, Central African Republic., Hermana G; National Tuberculosis Programme, Ministry of Public Health and Population, Bangui, Central African Republic., Ourandji LM; National Tuberculosis Programme, Ministry of Public Health and Population, Bangui, Central African Republic., Ignaleamoko A; Treatment Centre for Patients with Multi-drug-resistant Tuberculosis, University Hospital, Bangui, Central African Republic., Komangoya-Nzonzo AD; Focal Point for TB/VIH and Hepatitis, World Health Organization, Bangui, Central African Republic., Simelo JP; TB/HIV and Laboratories, Kinshasa, Democratic Republic of the Congo., Iragena JD; Communicable Diseases Cluster, HIV/TB and Hepatitis Programme, World Health Regional Office for Africa, Brazzaville, Congo.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2019 Feb 22; Vol. 6 (3), pp. ofz075. Date of Electronic Publication: 2019 Feb 22 (Print Publication: 2019).